Healing, Equity, Advocacy and Respect for Mamas
Comparing Standard of Care Versus a Technology-Based Approach To Reduce Postpartum Emergency Department Visits
Medical University of South Carolina
2,894 participants
May 28, 2024
INTERVENTIONAL
Conditions
Summary
The goal of the proposed research is to test the comparative effectiveness of AIM safety bundles for post-partum women delivered in-person vs. via text/phone to improve early detection of and timely care for complications during the first six weeks postpartum for women experiencing significant health disparities.
Eligibility
Inclusion Criteria4
- Postpartum woman within approximately 2 weeks of delivering a baby of gestational age ≥ 26 weeks in South Carolina.
- Aged 16-49 years old.
- Insured by Medicaid.
- \- OB provider working at a delivery hospital in SC and directly involved in the care of postpartum women; or hospital administrator working in a delivery hospital in SC and job responsibilities relate to the postpartum unit.
Exclusion Criteria10
- Plans to relocate outside of SC anytime during the postpartum year.
- Plans to discontinue Medicaid health insurance during the postpartum year.
- Speaks a language other than English or Spanish.
- Incarcerated/pending incarceration during peripartum period.
- Currently institutionalized.
- Enrolled in current MUSC study funded by PCORI (#Pro00123833)
- Does not have and/or does not wish to use their personal cell phone for the study.
- Less than 1 month of HEAR 4 Mamas experience if involved in the hospital where participants are recruited from.
- Unable or unwilling to commit to completing surveys or an interview.
- Speaking a language other than English.
Interventions
H.E.A.R. for Mamas is a patient and provider informed, multicomponent intervention that uses simple text/phone-based screenings to systematically and frequently monitor women for postpartum complications, chronic conditions and SDoH (Social Determinants of Health) and provides patients with immediate feedback and recommendations based on their screenings.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06273436